Back to results
US 2022/0089599 A1Published application
Alkynyl nicotinamide compounds as kinase inhibitors
AssigneePurdue Research Foundation
InventorsHERMAN O. SINTIM, ELIZABETH LAROCQUE, N. NAGANNA
Life of this patent
Estimating the term…
Abstract
This invention relates to Alkynyl Nicotinamide compounds and their derivatives as kinase inhibitors. In addition, uses thereof for treatment of disease such as cancer and, in particular, acute myeloid leukemia are disclosed.
Claims39
A compound represented by a compound of Formula (I):
- Wherein Y1-Y6==amide;
- O-alkyl such as OMe, OEt, OPr, OBu, OiPr, OCF2, OCF3;
- NH2, NH-alkyl, such as NHMe, NHEt;
- N-(alkyl)2 or N-(heteroalkyl)2, such as NMe2, morpholino, piperazine;
- CN, Cl, Br, iPr, Et, cyclopropyl, butyl, CF3, CHF2, CH2-piperazine analog, CH2-morpholine analog, CH2-piperidine analog, CH2-pyrrolidine analog, CH2-azetidine analog, etc. and X1-X7=CH, CY or N.
2 more elements
Dependencies are inferred from the claim text.